Julie Doostzadeh

Statistics

Publications

Citations

1.1K

H-Index

Active since

2006

Affiliations

Abbott Vascular (United States)(Current)

Abbott (United States)

Cardiovascular Research Foundation

Columbia University Irving Medical Center

Baim Institute for Clinical Research

Julie Doostzadeh is an author at Abbott Vascular (United States) specializing in interventional cardiology, cardiology, and percutaneous coronary intervention.

Publications per year

2006–2011

Publications

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Gregg W. Stone, Ali A. Rizvi, William Newman et al. · New England Journal of Medicine · 2010 · 896 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease

Eugenia Nikolsky, Alexandra J. Lansky, Krishnankutty Sudhir et al. · American Heart Journal · 2009 · 45 citations

Medicine, Cardiology, Surgery +12

Gender‐based evaluation of the XIENCE V™ everolimus‐eluting coronary stent system:

Alexandra J. Lansky, Vivian G. Ng, Halil Mutlu et al. · Catheterization and Cardiovascular Interventions · 2009 · 41 citations

Medicine, Cardiology, Surgery +17

Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)

Robert J. Applegate, Manejeh Yaqub, James Hermiller et al. · The American Journal of Cardiology · 2011 · 41 citations

Medicine, Cardiology, Interventional Cardiology +13

Randomized comparison of everolimus- and paclitaxel-eluting stents: pooled analysis of the 2-year clinical follow-up from the SPIRIT II and III trials

Yoshinobu Onuma, P. W. Serruys, N. Kukreja et al. · European Heart Journal · 2010 · 32 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

1–5 of 9